Non-Registered Director Im Gi-seop Increases Stake in Myungmoon Pharm to 0.26% with Open Market Purchase of 8,480 Shares

Myungmoon Pharm non-registered director Im Gi-seop purchased 8,480 common shares through open market transactions over three trading days from June 29 to July 1, 2026.
Acquisition prices ranged from 1,173 KRW to 1,254 KRW per share, with total investment of approximately 10.2 million KRW.
Following the purchase, Im's ownership increased from 0.24% to 0.26% of total outstanding shares of 33,953,454, a 0.02 percentage point rise.
This filing is a routine report of insider shareholding changes, unrelated to corporate capital actions or financing.
[AI Summary]The insider's small-scale share purchase may signal management confidence but the minor stake increase limits direct price impact. It should be viewed as a long-term commitment signal rather than a short-term catalyst.